← MHRA ALERTS
MHRA (UK) · DRUG SAFETY UPDATE13 February 2025

Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): review by two specialists is required for initiating valproate but not for male patients already taking valproate

Alert type
Drug Safety Update
Alert date
13 February 2025
Regulator
MHRA (United Kingdom)
READ THE FULL ALERT

The complete MHRA alert — the affected products, batches, and the action required — is published on GOV.UK. SPEQ surfaces and indexes it for reference; the authoritative notice lives on gov.uk.

View on gov.uk →
TURN IT INTO ACTION
About the MHRAThe UK regulator and the standards it enforces →Assess your quality systemBaseline against 12 GxP domains in 10 minutes →All MHRA alertsBrowse the live UK alert feed →

Alert details are published by the UK MHRA on GOV.UK; SPEQ surfaces them for reference and is not affiliated with or endorsed by the MHRA. The authoritative notice is on gov.uk.